Document is current
Any future updates will be listed below
-
Authors
Blanco, Daniel Bastardo
Chapman, Nicole M.
Raynor, Jana L.
Xu, Chengxian
Su, Wei https://orcid.org/0000-0003-4165-8776
KC, Anil
Li, Wei
Lim, Seon Ah
Schattgen, Stefan
Shi, Hao
Risch, Isabel https://orcid.org/0000-0003-3356-0349
Sun, Yu
Dhungana, Yogesh
Kim, Yunjung
Wei, Jun
Rankin, Sherri
Neale, Geoffrey https://orcid.org/0000-0003-3776-0858
Thomas, Paul G. https://orcid.org/0000-0001-7955-0256
Yang, Kai https://orcid.org/0000-0003-3103-5719
Chi, Hongbo https://orcid.org/0000-0002-9997-2496
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (AI105887, AI131703, AI150241, AI150514, CA253188)
U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health (AI140761)
- License Information
-
More Information
Article History
Received: 6 July 2021
Accepted: 12 September 2022
First Online: 27 October 2022
Competing interests
: H.C. is a consultant for Kumquat Biosciences, Inc. P.G.T. is on the scientific advisory board of Immunoscape and Cytoagents, and has consulted for or received personal fees from Mirror Biologics, PACT Pharma, Johnson & Johnson, Pfizer, 10X Genomics, Illumina and Elevate Bio, and has a sponsored research agreement with Elevate Bio. The remaining authors declare no competing interests.
